Target Development towards First Production of High-Molar- Activity 44g Sc and 47 Sc by Mass Separation at CERN-MEDICIS.

MLA

Mamis, Edgars, et al. “Target Development towards First Production of High-Molar- Activity 44g Sc and 47 Sc by Mass Separation at CERN-MEDICIS.” Pharmaceuticals (14248247), vol. 17, no. 3, Mar. 2024, p. 390. EBSCOhost, https://doi.org/10.3390/ph17030390.

APA

Mamis, E., Duchemin, C., Berlin, V., Bernerd, C., Bovigny, M., Chevallay, E., Crepieux, B., Gadelshin, V. M., Heinke, R., Hernandez, R. M., Johnson, J. D., Kalniņa, P., Koliatos, A., Lambert, L., Rossel, R. E., Rothe, S., Thiboud, J., Weber, F., Wendt, K., & Zabolockis, R. J. (2024). Target Development towards First Production of High-Molar- Activity 44g Sc and 47 Sc by Mass Separation at CERN-MEDICIS. Pharmaceuticals (14248247), 17(3), 390. https://doi.org/10.3390/ph17030390

Chicago

Mamis, Edgars, Charlotte Duchemin, Valentina Berlin, Cyril Bernerd, Mathieu Bovigny, Eric Chevallay, Bernard Crepieux, et al. 2024. “Target Development towards First Production of High-Molar- Activity 44g Sc and 47 Sc by Mass Separation at CERN-MEDICIS.” Pharmaceuticals (14248247) 17 (3): 390. doi:10.3390/ph17030390.